Aceto M. (1990) Assessment of physical dependence techniques for the evaluation of abused drugs. In Adler M W, Cowen A (eds), Testing and evaluation of drugs of abuse. Willey-Liss, New York, pp. 67-79
2.
Aranko K., Mattila J., Nuutila A., Pellinen J. (1985). Benzodiazepines, but not antidepressants or neuroleptics, induce dose-dependant tolerance to lorazepam in psychiatric patients. Acta Psychiatr Scand72: 436-46
3.
Baldessarini R., Viguera A., Tondo L. (1999a) Discontinuing psychotropic agents. J Psychopharmacol13: 292-3
4.
Baldessarini R., Tondo L., Viguera A. (1999b) Discontinuing lithium maintenance treatment in bipolar disorder: Risks and implications. Bipolar Disorders1: 17-24
5.
Chue P., Stip E., Remington G., Kopala L. (2004) Switching antipsychotics: a review. Acta Neuropsychiatr16: 301-13
6.
Davis J., Marder S., Tamminga C. (2006) Switch or stay?Am J Psychiatry163: 2032-3
7.
Essock S., Covell N., Davis S., Stroup T., Rosenheck R., Lieberman J. (2006) Effectiveness of switching antipsychotics. Am J Psychiatry163: 2090-5
8.
Fernandez H., Trieschmann, M., Okun M. ( 2005) Rebound psychoses: Effect of discontinuation of antipsychotics in Parkinson's disease. Movement Disorders20: 104-15
9.
Gerlach J., Koppelhus P., Helweg E., Manrad A. (1974) Clozapine and haloperidol in a single-blind cross-over trial. Therapeutic and biochemical aspects in the treatment of schizophrenia . Acta Psychiatr Scand50: 410-24
10.
Goudie A. (2000) What is the clinical significance of the discontinuation syndrome seen with clozapine?J Psychopharmacol14: 188-92
11.
Goudie A., Smith J., Robertson A., Cavanagh C. (1999) Clozapine as a drug of dependence. Psychopharmacology142: 369-74
12.
Goudie A., Cooper G., Cole J., Sumnall H. (2007a) Cyproheptadine resembles clozapine in vivo following both acute and chronic administration in rats. J Psychopharmacol21: 171-90
13.
Goudie A., Cole J., Sumnall H. (2007b) Olanzapine and JL 13 induce cross-tolerance to the clozapine discriminative stimulus in rats. Behav Pharmacol18: 9-17
14.
Goudie A., Cole J., Sumnall H. (2007c) Olanzapine withdrawal/discontinuation-induced hyperthermia in rats. Progress in Neuropsychopharmacology and Biological Psychiatry31: 1500-03
15.
Grassi B., Ferrari R., Epifani M., Dragoni C., Cohen S., Scarone S. (1999) Clozapine lacks previous clinical efficacy when restarted after a period of discontinuation: a case series. Eur Neuropsychopharmacol9: 479-81
16.
Haro J, Novick D, Belger M, Jones P, SOHO Advisory Board (2006) Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia. Eur Psychiatry21: 41-7
17.
Lieberman J., Stroup T., McEvoy J., Swartz M., Rosenheck R., Perkins D., Keefe R., Davis S., Davis C., Lebowitz B., Severe J., Hsiao J. (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England J Med353: 1209-23
18.
Llorca P., Vaiva G., Lancon C. (2001) Supersensitivity psychosis in patients after sudden olanzapine withdrawal. Can J Psychiatry46: 87-8
19.
Margolese H., Chouinard G., Beauclair L., Bellanger M-C. (2002) Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients. J Clin Psychopharmacol20: 489-90
20.
Meltzer H., Lee M., Ranjan R., Mason E., Cola P. ( 1996). Relapse following clozapine withdrawal. Psychopharmacology124: 176-87
21.
Miodownik C., Lerner V., Kibari A., Toder D., Cohen H. (2006) The effect of sudden clozapine discontinuation on management of schizophrenic patients: a retrospective controlled study . J Clin Psychiatry67: 1204-8
22.
National Collaborating Centre for Mental Health ( 2003) Full national clinical guidelines on core interventions in primary and secondary care for schizophrenia. Gaskell and British Psychological Society, London and Leicester, ISBN 1-901242-97- 8
23.
Nayudu S., Scheftner W. (2000) Case report of withdrawal syndrome after olanzapine discontinuation. J Clin Psychopharmacol20: 489-90
24.
Sabuncuoglu O. (2007) Risperidone to methylphenidate switch reaction in children: three cases. J Psychopharmacol21: 216-9
25.
Samaha A., Seeman P., Stewart J., Rajabi H., Kapur S. (2007) "Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time. J Neuroscience27: 2979-86
26.
Seppala N., Kovio C., Leinonen E. (2005) Effects of anticholinergic drugs in preventing acute deterioration in patients undergoing abrupt clozapine withdrawal. CNS Drugs19: 1049-55
27.
Tollefson G., Dellva M., Mattler C., Kane J., Wirshing D., Kinon B. (1999) Controlled double-blind investigation of clozapine discontinuation symptoms with conversion to either olanzapine or placebo. J Clin Psychopharmacol19: 435-43
28.
Viguera A., Baldessarini R., Hegarty J., Van Kammen D., Tohen M. (1997) Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry54: 49-55
29.
Weiden P. (2006) Switching antipsychotics: an updated review with a focus on quetiapine. J Psychopharmacol20: 104-8
